Programmed death 1 is expressed in cutaneous infiltrates of mycosis fungoides and Sézary syndrome

American Journal of Hematology

Volumn 86, Issue 3, 2011, Pages 325-327

  Wada, David A ^a   Wilcox, Ryan A ^a   Harrington, Susan M ^a   Kwon, Eugene D ^a   Ansell, Stephen M ^a   Comfere, Nneka I ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 RECEPTOR;

CANCER CELL; CLINICAL ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LETTER; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEZARY SYNDROME; SKIN BIOPSY;

ANTIGENS, CD; APOPTOSIS REGULATORY PROTEINS; CASE-CONTROL STUDIES; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MYCOSIS FUNGOIDES; NEOPLASM PROTEINS; SEZARY SYNDROME; SKIN NEOPLASMS; T-LYMPHOCYTES;

EID: 79951936838     PISSN: 03618609     EISSN: 10968652     Source Type: Journal    
DOI: 10.1002/ajh.21960     Document Type: Letter

References (16)

1. Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26: 677-704.
2. PDQ®: NCI's Comprehensive Cancer Database [Internet] n.d. Bethesda (MD): National Cancer Institute (US). Clinical trials (PDQ): A phase 1b study of MDX-1106 in subjects with advanced or recurrent malignancies; [cited 2008 Nov 23; about 5 screens]. Available at:
3. Iwai Y, Okazaki T, Nishimura H, et al. Microanatomical localization of PD-1 in human tonsils. Immunol Lett 2002; 83: 215-220.
4. Dorfman DM, Brown JA, Shahsafaei A, Freeman GJ. Programmed death-1 (PD-1) is a marker of germinal center-associated T cells and angioimmunoblastic T-cell lymphoma. Am J Surg Pathol 2006; 30: 802-810.
5. Roncador G, Garcia Verdes-Montenegro JF, Tedoldi S, et al. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica 2007; 92: 1059-1066.
6. Rodriguez-Pinilla SM, Atienza L, Murillo C, et al. Peripheral T-cell lymphoma with follicular T-cell markers. Am J Surg Pathol 2008; 32: 1787-1799.
7. Xerri L, Chetaille B, Seriari N, et al. Programmed death 1 is a marker of angioimmunoblastic T-cell lymphoma and B-cell small lymphocytic lymphoma/chronic lymphocytic leukemia. Hum Pathol 2008; 39: 1050-1058.
8. + T-cells in adult T-cell leukemia/lymphoma. Int J Cancer 2007; 121: 2585-2590.
9. Day CL, Kaufmann DE, Kiepiela P, et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006; 443: 350-354.
10. Urbani S, Amadei B, Tola D, et al. PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. J Virol 2006; 80: 11398-11403.
11. Carney DN, Bunn PAJr., Schechter GP, Gazdar AF. Lymphocyte transformation in patients with cutaneous T-cell lymphomas. Int J Cancer 1980; 26: 535-542.
12. Meech SJ, Edelson R, Walsh P, et al. Reversible resistance to apoptosis in cutaneous T cell lymphoma. Ann N Y Acad Sci 2001; 941: 46-58.
13. Azuma T, Yao S, Zhu G, et al. B7-H1 is a ubiquitous antiapoptotic receptor on cancer cells. Blood 2008; 111: 3635-3643.
14. Wilcox RA, Feldman AL, Wada DA, et al. B7-H1 (PD-L1, CD274) suppresses host immunity in T-cell lymphoproliferative disorders. Blood 2009; 114: 2149-2158.
15. Brahmer JR, Drake CG, Wollner I, et al. Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: Safety, clinical activity, pharmacodynamics, and immunologic correlates. J Clin Oncol 2010; 28: 3167-3175.
16. Boorjian SA, Sheinin Y, Crispen PL, et al. T-cell coregulatory molecule expression in urothelial cell carcinoma: Clinicopathologic correlations and association with survival. Clin Cancer Res 2008; 14: 4800-4808.